Court: Can generic drug maker be sued over design?

Published



WASHINGTON (AP) — The Supreme Court seemed skeptical Tuesday of allowing generic drug manufacturers to be sued in state court for a drug’s design defects if federal officials approved the brand-name version the generic drug copied.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.